American College of Cardiology

BONOW ET AL., ACC/AHA TASK FORCE REPORT
JACC Vol. 32, No. 5, November 1998:1486-1588

ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease

References

2. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the Clinical Application of Echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography), developed in collaboration with the American Society of Echocardiography. Circulation 1997;95:1686-1744.

3. Gibbons RJ, Beasley JW, Bricker JT, et al. ACC/AHA Guidelines for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-311.

4. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol In press.

5. Shaver JA, Leonard JJ, Leon DF, on behalf of the Council on Clinical Cardiology of the American Heart Association. Examination of the Heart, Part 4: Auscultation of the Heart. Dallas, TX: American Heart Association; 1990.

6. Shaver JA, Salerni R. Auscultation of the heart. In: Schlant RA, Alexander RW, eds. The Heart. 8th ed. New York, NY: McGraw-Hill Publishing Co; 1994:253-314.

7. Leatham A. Systolic murmurs. Circulation 1958;17:601-611.

8. O'Rourke RA, Braunwald E. Physical examination of the cardiovascular system. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill Publishing Co; 1998.

9. Shaver JA. Cardiac auscultation: a cost-effective diagnostic skill. Curr Probl Cardiol 1995;20:441-530.

10. Grewe K, Crawford MH, O'Rourke RA. Differentiation of cardiac murmurs by dynamic auscultation. Curr Probl Cardiol 1988;13:669-721.

11. Lembo NJ, Dell'Italia LJ, Crawford MH, O'Rourke RA. Bedside diagnosis of systolic murmurs. N Engl J Med 1988;318:1572-1578.

12. Karliner JS, O'Rourke RA, Kearney DJ, Shabetai R. Haemodynamic explanation of why the murmur of mitral regurgitation is independent of cycle length. Br Heart J 1973;35:397-401.

13. Lembo NJ, Dell'Italia LJ, Crawford MH, O'Rourke RA. Diagnosis of left-sided regurgitant murmurs by transient arterial occlusion: a new maneuver using blood pressure cuffs. Ann Intern Med 1986;105:368-370.

14. Harvey WP. Cardiac pearls. Dis Mon 1994;40:41-113.

15. Xu M, McHaffie DJ. Nonspecific systolic murmurs: an audit of the clinical value of echocardiography. N Z Med J 1993;106:54-56.

16. Smythe JF, Teixeira OH, Vlad P, Demers PP, Feldman W. Initial evaluation of heart murmurs: are laboratory tests necessary? Pediatrics 1990;86:497-500.

17. O'Rourke RA. Heart murmur. In: Braunwald E, Goldman L, eds. Primary Cardiology. Philadelphia, Pa: WB Saunders Co; 1998.

18. Yoshida K, Yoshikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988;78:840-847.

19. Sahn DJ, Maciel BC. Physiological valvular regurgitation: Doppler echocardiography and the potential for iatrogenic heart disease. Circulation 1988;78:1075-1077.

20. Klein AL, Burstow DJ, Tajik AJ, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr 1990;3:54-63.

21. Fink JC, Schmid CH, Selker HP. A decision aid for referring patients with systolic murmurs for echocardiography. J Gen Intern Med 1994;9:479-484.

22. Choong CY, Abascal VM, Weyman J, et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am Heart J 1989;117:636-642.

23. Abrams J. Essentials of Cardiac Physical Diagnosis. Philadelphia, Pa: Lea & Febiger; 1987.

24. Mishra M, Chambers JB, Jackson G. Murmurs in pregnancy: an audit of echocardiography. BMJ 1992;304:1413-1414.

25. Northcote RJ, Knight PV, Ballantyne D. Systolic murmurs in pregnancy: value of echocardiographic assessment. Clin Cardiol 1985;8:327-328.

26. Durack DT, Beeson PB. Experimental bacterial endocarditis, I: colonization of a sterile vegetation. Br J Exp Pathol 1972;53:44-49.

27. Bansal RC. Infective endocarditis. Med Clin North Am 1995;79:1205-1240.

28. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38-44.

29. Imperiale TF, Horwitz RI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990;88:131-136.

30. Horstkotte D, Rosin H, Friedrichs W, Loogen F. Contribution for choosing the optimal prophylaxis of bacterial endocarditis. Eur Heart J 1987;8:379-381.

31. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis: analysis of 52 cases submitted to a national registry. JAMA 1983;250:2318-2322.

32. Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992;339:135-139.

33. Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis: a review. Medicine (Baltimore). 1977;56:61-77.

34. Kaye D. Prophylaxis for infective endocarditis: an update. Ann Intern Med 1986;104:419-423.

35. Pallasch TJ. A critique of antibiotic prophylaxis. CDA J 1986;14:28-36.

36. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 1997;96:358-366.

37. Stoddard MF, Prince CR, Dillon S, Longaker RA, Morris GT, Liddell NE. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Coll Cardiol 1995;25:693-699.

38. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990;336:1167-1171.

39. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-793.

40. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals: Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96:758-764.

41. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 1987;317:91-98.

42. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc 1987;62:119-123.

43. Stephan PJ, Henry AC, Hebeler RF, Whidden L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 1997;79:166-172.

44. Bruns DL, Van der Hauwaert LG. The aortic systolic murmur developing with increasing age. Br Heart J 1958;20:370-378.

45. McMillan IKR. Aortic stenosis: a postmortem cinephotographic study of valve action. Br Heart J 1955;17:56.

46. Wood P. Aortic stenosis. Am J Cardiol 1958;1:553.

46a.Rahimtoola SH. Perspective on valvular heart disease: an update. J Am Coll Cardiol 1989;14:1-23.

47. Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976;38:172-178.

48. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol 1979;43:1189-1194.

49. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980;62:576-582.

50. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988;9(suppl E):19-23.

51. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979;59:679-688.

52. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976;18:255-264.

53. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation 1981;64:126-134.

54. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980;62:42-48

55. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 1976;38:645-653.

56. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984;69:855-865.

57. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP. Diastolic filling dynamics in patients with aortic stenosis. Circulation 1986;73:1162-1174.

58. Dineen E, Brent BN. Aortic valve stenosis: comparison of patients with to those without chronic congestive heart failure. Am J Cardiol 1986;57:419-422.

59. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994;271:1276-1280.

60. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE. The role of left atrial transport in aortic and mitral stenosis. Circulation 1970;41:1031-1041.

61. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982;307:1362-1366.

62. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res 1981;48:76-87.

63. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982;50:55-62.

64. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation 1982;65:1192-1197.

65. Gaasch WH, Zile MR, Hoshino PK, et al. Tolerance of the hypertrophic heart to ischemia: studies in compensated and failing dog hearts with pressure overload hypertrophy. Circulation 1990;81:1644-1653.

66. Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuenoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis: a marker for high postoperative morbidity and mortality. Circulation 1992;86:926-936.

67. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992;86:1099-1107.

68. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis: a high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993;22:1679-1683.

69. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 1994;74:794-798.

70. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985;312:277-283.

71. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am Heart J 1996;132:408-417.

72. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode RS Jr. Rate of progression of severity of valvular aortic stenosis in the adult. Am Heart J 1979;98:689-700.

73. Wagner S, Selzer A. Patterns of progression of aortic stenosis: a longitudinal hemodynamic study. Circulation 1982;65:709-712.

74. Cha SD, Naeem SM, Maranhao V, Gooch AS. Sequential study of left ventricular function in aortic valvular stenosis. Cathet Cardiovasc Diagn 1982;8:145-154.

75. Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A. Rate of progression of severity of valvular aortic stenosis. Acta Med Scand 1983;213:51-54.

76. Nestico PF, DePace NL, Kimbiris D, et al. Progression of isolated aortic stenosis: analysis of 29 patients having more than 1 cardiac catheterization. Am J Cardiol 1983;52:1054-1058.

77. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471-483.

78. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 1991;12:10-14.

79. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989;13:545-550.

80. Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 1990;119:331-338.

81. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992;70:229-233.

82. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis: role of age and concomitant coronary artery disease. Chest 1993;103:1715-1719.

83. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol 1995;25:305-310.

84. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270.

85. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38:61-67.

86. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-1110.

87. Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J 1995;74:481-484.

88. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988;9(suppl E):57-64.

89. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996;78:97-101.

90. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol 1988;61:123-130.

91. Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980;99:419-424.

92. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15:1012-1017.

93. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br Heart J 1973;35:41-46.

94. Nylander E, Ekman I, Marklund T, Sinnerstad B, Karlsson E, Wranne B. Severe aortic stenosis in elderly patients. Br Heart J 1986;55:480-487.

95. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testing in patients with aortic stenosis. Chest 1988;93:1083-1087.

96. Clyne CA, Arrighi JA, Maron BJ, Bonow RO, Cannon RO. Systemic and left ventricular responses to exercise stress of asymptomatic patients with valvular aortic stenosis. Am J Cardiol 1991;68:1469-1476.

97. Otto CM, Pearlman AS, Kraft CD, Miyake-Hull CY, Burwash IG, Gardner CJ. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 1992;20:1160-1167.

98. Keller AM, Peshock RM, Malloy CR, et al. In vivo measurement of myocardial mass using nuclear magnetic resonance imaging. J Am Coll Cardiol 1986;8:113-117.

99. Van Rossum AC, Visser FC, Sprenger M, Van Eenige MJ, Valk J, Roos JP. Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography. Am J Cardiol 1988;62:628-633.

100. Buser PT, Auffermann W, Holt WW, et al. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance. J Am Coll Cardiol 1989;13:1294-1300.

101. Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging: validation by calibrated ventricular angiography. Circulation 1990;82:154-163.

102. Benjelloun H, Cranney GB, Kirk KA, Blackwell GG, Lotan CS, Pohost GM. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol 1991;67:1413-1420.

103. Eichenberger AC, Jenni R, von Schulthess GK. Aortic valve pressure gradients in patients with aortic valve stenosis: quantification with velocity-encoded cine MR imaging. Am J Roentgenol. 1993;160:971-977.

104. Sondergaard L, Hildebrandt P, Lindvig K, et al. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. Am Heart J. 1993;126:1156-1164.

105. Cheitlin MD, Douglas PS, Parmley WW. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. J Am Coll Cardiol 1994;24:874-880.

106. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of stenotic mitral valve, other cardiac values and central circulatory shunts. Am Heart J. 1951;41:1-29.

107. Ford LE, Feldman T, Chiu YC, Carroll JD. Hemodynamic resistance as a measure of functional impairment in aortic valvular stenosis. Circ Res 1990;66:1-7.

108. Cannon JD, Zile MR, Crawford FA, Carabello BA. Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients. J Am Coll Cardiol. 1992;20:1517-1523.

109. Bache RJ, Wang Y, Jorgensen CR. Hemodynamic effects of exercise in isolated valvular aortic stenosis. Circulation 1971;44:1003-1013.

110. deFilippi CR, Willett DL, Brickner ME, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75:191-194.

111. Bermejo J, Garcia-Fernandez MA, Torrecilla EG, et al. Effects of dobutamine on Doppler echocardiographic indexes of aortic stenosis. J Am Coll Cardiol 1996;28:1206-1213.

112. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978;58:255-264.

113. Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 1981;64:II-184-II-188.

114. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention. Circulation 1990;82:124-139.

115. Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF, Perrillo JB. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med 1994;330:1-6.

116. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators. Circulation 1997;95:2395-2400.

117. Brogan WC III, Grayburn PA, Lange RA, Hillis LD. Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient. J Am Coll Cardiol 1993;21:1657-1660.

118. Carabello BA. Timing of valve replacement in aortic stenosis: moving closer to perfection. Circulation 1997;95:2241-2243.

119. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-416.

120. Akins CW. Mechanical cardiac valvular prostheses. Ann Thorac Surg 1991;52:161-172.

121. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573-579.

122. Yacoub M, Rasmi NR, Sundt TM, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-193; discussion 193-194.

123. O'Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995;60:S65-S70.

124. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis: Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 1993;328:1289-1296.

125. Lund O, Larsen KE. Cardiac pathology after isolated valve replacement for aortic stenosis in relation to preoperative patient status: early and late autopsy findings. Scand J Thorac Cardiovasc Surg 1989;23:263-270.

126. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol 1984;53:194-197.

127. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986;1:63-67.

128. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplasty in 170 consecutive patients. N Engl J Med 1988;319:125-130.

129. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation 1986;74:119-125.

130. Safian RD, Mandell VS, Thurer RE, et al. Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am Coll Cardiol 1987;9:655-660.

131. Isner JM, Samuels DA, Slovenkai GA, et al. Mechanism of aortic balloon valvuloplasty: fracture of valvular calcific deposits. Ann Intern Med 1988;108:377-380.

132. Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis. Am J Cardiol 1988;62:598-605.

133. Block PC, Palacios IF. Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. Am J Cardiol 1988;62:760-763.

134. Sherman W, Hershman R, Lazzam C, Cohen M, Ambrose J, Gorlin R. Balloon valvuloplasty in adult aortic stenosis: determinants of clinical outcome. Ann Intern Med 1989;110:421-425.

135. Brady ST, Davis CA, Kussmaul WG, Laskey WK, Hirshfeld JW Jr, Herrmann HC. Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality. Ann Intern Med 1989;110:761-766.

136. Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS. Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures. Mayo Clin Proc 1989;64:753-757.

137. Fields CD, Rosenfield K, Lasordo DW, Isner JM. Percutaneous balloon valvuloplasty: current status. Curr Opinion Cardiol 1989;4:229-242.

138. Ferguson JJ, Riuli EP, Massumi A, et al. Balloon aortic valvuloplasty: the Texas Heart Institute experience. Tex Heart Inst J 1990;17:23-30.

139. Berland J, Cribier A, Savin T, Lefebvre E, Koning R, Letac B. Percutaneous balloon valvuloplasty in patients with severe aortic stenosis and low ejection fraction: immediate results and 1-year follow-up. Circulation 1989;79:1189-1196.

140. Davidson CJ, Harrison JK, Leithe ME, Kisslo KB, Bashore TM. Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function. Am J Cardiol 1990;65:72-77.

140a. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642-650.

141. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522-1528.

142. Block PC. Aortic valvuloplasty-a valid alternative? N Engl J Med 1988;319:169-171.

143. Nishimura RA, Holmes DR, Reeder GS. Percutaneous balloon valvuloplasty. Mayo Clin Proc 1990;65:198-220.

144. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994;23:1076-1078.

145. O'Keefe JH, Shub C, Rettke SR. Risk of noncardiac surgical procedures in patients with aortic stenosis. Mayo Clin Proc 1989;64:400-405.

146. Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 1998;81:448-452.

147. Tsai TP, Denton TA, Chaux A, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients 90 years of age. Am J Cardiol 1994;74:960-962.

148. Logeais Y, Langanay T, Roussin R, et al. Surgery for aortic stenosis in elderly patients: a study of surgical risk and predictive factors. Circulation 1994;90:2891-2898.

149. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9.

150. Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Diagnostic imaging in the evaluation of suspected aortic dissection: old standards and new directions. N Engl J Med 1993;328:35-43.

151. Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. N Engl J Med 1995;332:356-362.

152. Rahimtoola SH. Recognition and management of acute aortic regurgitation. Heart Dis Stroke 1993;2:217-221.

153. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.

154. Ross J Jr, McCullagh WH. Nature of enhanced performance of the dilated left ventricle in the dog during chronic volume overloading. Circ Res 1972;30:549-556.

155. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984;3:916-923.

156. Carabello BA. Aortic regurgitation: a lesion with similarities to both aortic stenosis and mitral regurgitation. Circulation 1990;82:1051-1053.

157. Ricci DR. Afterload mismatch and preload reserve in chronic aortic regurgitation. Circulation 1982;66:826-834.

158. Ross J Jr. Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol 1985;5:811-826.

159. Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am Coll Cardiol 1988;11:478-486.

160. Gaasch WH, Andrias CW, Levine HJ. Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function. Circulation 1978;58:825-836.

161. Schwarz F, Flameng W, Langebartels F, Sesto M, Walter P, Schlepper M. Impaired left ventricular function in chronic aortic valve disease: survival and function after replacement by Bjork-Shiley prosthesis. Circulation 1979;60:48-58.

162. Borer JS, Rosing DR, Kent KM, et al. Left ventricular function at rest and during exercise after aortic valve replacement in patients with aortic regurgitation. Am J Cardiol 1979;44:1297-1305.

163. Clark DG, McAnulty JH, Rahimtoola SH. Valve replacement in aortic insufficiency with left ventricular dysfunction. Circulation 1980;61:411-421.

164. Toussaint C, Cribier A, Cazor JL, Soyer R, Letac B. Hemodynamic and angiographic evaluation of aortic regurgitation 8 and 27 months after aortic valve replacement. Circulation 1981;64:456-463.

165. Carroll JD, Gaasch WH, Zile MR, Levine HJ. Serial changes in left ventricular function after correction of chronic aortic regurgitation: dependence on early changes in preload and subsequent regression of hypertrophy. Am J Cardiol 1983;51:476-482.

166. Bonow RO, Rosing DR, Maron BJ, et al. Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 1984;70:570-579.

167. Fioretti P, Roelandt J, Sclavo M, et al. Postoperative regression of left ventricular dimensions in aortic insufficiency: a long-term echocardiographic study. J Am Coll Cardiol 1985;5:856-861.

168. Carabello BA, Usher BW, Hendrix GH, Assey ME, Crawford FA, Leman RB. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol 1987;10:991-997.

169. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for aortic regurgitation. J Am Coll Cardiol 1987;10:510-518.

170. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 1988;78:1108-1120.

171. Borer JS, Herrold EM, Hochreiter C, et al. Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. Circulation 1991;84:III133-III-139.

172. Cohn PF, Gorlin R, Cohn LH, Collins JJ Jr. Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol 1974;34:136-141.

173. Copeland JG, Griepp RB, Stinson EB, Shumway NE. Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg 1977;74:875-889.

174. Herreman F, Ameur A, de Vernejoul F, et al. Pre- and postoperative hemodynamic and cineangiocardiographic assessment of left ventricular function in patients with aortic regurgitation. Am Heart J 1979;98:63-72.

175. Forman R, Firth BG, Barnard MS. Prognostic significance of preoperative left ventricular ejection fraction and valve lesion in patients with aortic valve replacement. Am J Cardiol 1980;45:1120-1125.

176. Cunha CL, Giuliani ER, Fuster V, Seward JB, Brandenburg RO, McGoon DC. Preoperative M-mode echocardiography as a predictor of surgical results in chronic aortic insufficiency. J Thorac Cardiovasc Surg 1980;79:256-265.

177. Greves J, Rahimtoola SH, McAnulty JH, et al. Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation. Am Heart J 1981;101:300-308.

178. Gaasch WH, Carroll JD, Levine HJ, Criscitiello MG. Chronic aortic regurgitation: prognostic value of left ventricular end-systolic dimension and end-diastolic radius/thickness ratio. J Am Coll Cardiol 1983;1:775-782.

179. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation 1985;72:1244-1256.

180. Carabello BA, Williams H, Gash AK, et al. Hemodynamic predictors of outcome in patients undergoing valve replacement. Circulation 1986;74:1309-1316.

181. Michel PL, Iung B, Jaoude SA, et al. The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation. J Heart Valve Dis 1995;4:S160-S168.

182. Henry WL, Bonow RO, Borer JS, et al. Observations on the optimum time for operative intervention for aortic regurgitation, I: evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980;61:471-483.

183. Kumpuris AG, Quinones MA, Waggoner AD, Kanon DJ, Nelson JG, Miller RR. Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency. Am J Cardiol 1982;49:1091-1100.

184. Fioretti P, Roelandt J, Bos RJ, et al. Echocardiography in chronic aortic insufficiency: is valve replacement too late when left ventricular end-systolic dimension reaches 55 mm? Circulation 1983;67:216-221.

185. Stone PH, Clark RD, Goldschlager N, Selzer A, Cohn K. Determinants of prognosis of patients with aortic regurgitation who undergo aortic valve replacement. J Am Coll Cardiol 1984;3:1118-1126.

186. Daniel WG, Hood WP Jr, Siart A, et al. Chronic aortic regurgitation: reassessment of the prognostic value of preoperative left ventricular end-systolic dimension and fractional shortening. Circulation 1985;71:669-680.

187. Cormier B, Vahanian A, Luxereau P, Kassab R, Acar J. Should asymptomatic or mildly symptomatic aortic regurgitation be operated on? Z Kardiol 1986;75(suppl 2):141-145.

188. Sheiban I, Trevi GP, Casarotto D, et al. Aortic valve replacement in patients with aortic incompetence: preoperative parameters influencing long-term results. Z Kardiol 1986;75(suppl 2):146-154.

189. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction. J Am Coll Cardiol 1996;27:670-677.

190. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 1983;68:509-517.

191. Scognamiglio R, Fasoli G, Dalla Volta S. Progression of myocardial dysfunction in asymptomatic patients with severe aortic insufficiency. Clin Cardiol 1986;9:151-156.

192. Siemienczuk D, Greenberg B, Morris C, et al. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. Ann Intern Med 1989;110:587-592.

193. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-1635.

194. Tornos MP, Olona M, Permanyer-Miralda G, et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am Heart J 1995;130:333-339.

195. Ishii K, Hirota Y, Suwa M, Kita Y, Onaka H, Kawamura K. Natural history and left ventricular response in chronic aortic regurgitation. Am J Cardiol 1996;78:357-361.

196. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-694.

197. Borer JS, Hochreiter C, Herrold EM, et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998;97:525-534.

198. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency: a randomized double-blinded, placebo-controlled clinical trial. Circulation 1988;78:92-103.

199. Shen WF, Roubin GS, Choong CYP, et al. Evaluation of relationship between myocardial contractile state and left ventricular function in patients with aortic regurgitation. Circulation 1985;71:31-38.

200. Lewis SM, Riba AL, Berger HJ, et al. Radionuclide angiographic exercise left ventricular performance in chronic aortic regurgitation: relationship to resting echographic ventricular dimensions and systolic wall stress index. Am Heart J 1982;103:498-504.

201. Goldman ME, Packer M, Horowitz SF, et al. Relation between exercise-induced changes in ejection fraction and systolic loading conditions at rest in aortic regurgitation. J Am Coll Cardiol 1984;3:924-929.

202. Greenberg B, Massie B, Thomas D, et al. Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency. Circulation 1985;71:458-465.

203. Kawanishi DT, McKay CR, Chandraratna AN, et al. Cardiovascular response to dynamic exercise in patients with chronic symptomatic mild-to-moderate and severe aortic regurgitation. Circulation 1986;73:62-72.

204. Henry WL, Bonow RO, Rosing DR, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation 1980;61:484-492.

205. McDonald IG, Jelinek VM. Serial M-mode echocardiography in severe chronic aortic regurgitation. Circulation 1980;62:1291-1296.

206. Bonow RO. Radionuclide angiography in the management of asymptomatic aortic regurgitation. Circulation 1991;84:I-296-I-302.

207. Hegglin R, Scheu H, Rothlin M. Aortic insufficiency. Circulation 1968;38:77-92.

208. Spagnuolo M, Kloth H, Taranta A, Doyle E, Pasternack B. Natural history of rheumatic aortic regurgitation: criteria predictive of death, congestive heart failure, and angina in young patients. Circulation 1971;44:368-380.

209. Rapaport E. Natural history of aortic and mitral valve disease. Am J Cardiol 1975;35:221-227.

210. Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction. Am J Cardiol 1994;74:286-288.

211. Parker E, Craige E, Hood WP. The Austin Flint murmur and the a wave of the apexcardiogram in aortic regurgitation. Circulation 1971;43:349-359.

212. Fortuin NJ, Craige E. On the mechanism of the Austin Flint murmur. Circulation 1972;45:558-570.

213. Harvey WP, Corrado MA, Perloff JK. "Right-sided" murmurs of aortic insufficiency (diastolic murmurs better heard to the right of the sternum rather than to the left). Am J Med Sci 1963;61:533-542.

214. Teague SM, Heinsimer JA, Anderson JL, et al. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol 1986;8:592-599.

215. Labovitz AJ, Ferrara RP, Kern MJ, Bryg RJ, Mrosek DG, Williams GA. Quantitative evaluation of aortic insufficiency by continuous wave Doppler echocardiography. J Am Coll Cardiol 1986;8:1341-1347.

216. Xie GY, Berk MR, Smith MD, DeMaria AN. A simplified method for determining regurgitant fraction by Doppler echocardiography in patients with aortic regurgitation. J Am Coll Cardiol 1994;24:1041-1045.

217. Borer JS, Bacharach SL, Green MV, et al. Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol 1978;42:351-357.

218. Huxley RL, Gaffney FA, Corbett JR, et al. Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy. Am J Cardiol 1983;51:1542-1550.

219. Iskandrian AS, Hakki AH, Manno B, Amenta A, Kane SA. Left ventricular function in chronic aortic regurgitation. J Am Coll Cardiol 1983;1:1374-1380.

220. Gerson MC, Engel PJ, Mantil JC, Bucher PD, Hertzberg VS, Adolph RJ. Effects of dynamic and isometric exercise on the radionuclide-determined regurgitant fraction in aortic insufficiency. J Am Coll Cardiol 1984;3:98-106.

221. Massie BM, Kramer BL, Loge D, et al. Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: relation to simultaneous hemodynamic measurements. J Am Coll Cardiol 1985;5:847-855.

222. Wilson RA, Greenberg BH, Massie BM, et al. Left ventricular response to submaximal and maximal exercise in asymptomatic aortic regurgitation. Am J Cardiol 1988;62:606-610.

223. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-1091.

224. Bolen JL, Alderman EL. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 1976;53:879-883.

225. Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Am J Cardiol 1976;38:564-567.

226. Greenberg BH, DeMots H, Murphy E, Rahimtoola S. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation 1980;62:49-55.

227. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency. Circulation 1981;63:263-268.

228. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini F. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol 1982;49:1728-1732.

229. Shen WF, Roubin GS, Hirasawa K, et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol 1984;4:902-907.

230. Scognamiglio R, Fasoli G, Visintin L, Dalla-Volta S. Effects of unloading and positive inotropic interventions on left ventricular function in asymptomatic patients with chronic severe aortic insufficiency. Clin Cardiol 1987;10:804-810.

231. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation. Am J Cardiol 1993;72:799-804.

232. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:424-429.

233. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994;3:197-204.

234. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994;24:1046-1053.

235. Schon HR, Dorn R, Barthel P, Schomig A. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994;3:500-509.

236. Sechtem U, Pflugfelder PW, Cassidy MM, et al. Mitral or aortic regurgitation: quantification of regurgitant volumes with cine MR imaging. Radiology 1988;167:425-430.

237. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992;185:235-240.

238. Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1994;23:951-958.

239. Walker PG, Oyre S, Pedersen EM, Houlind K, Guenet FS, Yoganathan AP. A new control volume method for calculating valvular regurgitation. Circulation 1995;92:579-586.

240. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation: comparison with invasive techniques. Circulation 1995;92:1151-1158.

241. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction. Cardiol Clin 1995;13:73-83.

242. Nishimura RA, McGoon MD, Schaff HV, Giuliani ER. Chronic aortic regurgitation: indications for operation-1988. Mayo Clin Proc 1988;63:270-280.

243. Bonow RO. Asymptomatic aortic regurgitation: indications for operation. J Card Surg 1994;9:170-173.

244. Rahimtoola SH. Valve replacement should not be performed in all asymptomatic patients with severe aortic incompetence. J Thorac Cardiovasc Surg 1980;79:163-172.

245. Carabello BA. The changing unnatural history of valvular regurgitation. Ann Thorac Surg 1992;53:191-199.

246. Gaasch WH, Sundaram M, Meyer TE. Managing asymptomatic patients with chronic aortic regurgitation. Chest 1997;111:1702-1709.

247. Turina J, Turina M, Rothlin M, Krayenbuehl HP. Improved late survival in patients with chronic aortic regurgitation by earlier operation. Circulation 1984;70:I-147-I-152.

248. Gash AK, Carabello BA, Kent RL, Frazier JA, Spann JF. Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency. J Am Coll Cardiol 1984;3:703-711.

249. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Surgery for aortic regurgitation in women: contrasting indications and outcomes compared with men. Circulation 1996;94:2472-2478.

250. Lindsay J Jr, Beall AC Jr, DeBakey ME. Diagnosis and treatment of diseases of the aorta. In: Schlant R, Alexander RW, eds. Hurst's The Heart. 9th ed. New York, NY: McGraw-Hill Publishing Co; 1998:2461-2482.

251. Boucher CA, Bingham JB, Osbakken MD, et al. Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol 1981;47:991-1004.

252. Schuler G, Peterson KL, Johnson AD, et al. Serial noninvasive assessment of left ventricular hypertrophy and function after surgical correction of aortic regurgitation. Am J Cardiol 1979;44:585-594.

253. Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients 80 years and older: operative risks and long-term results. Circulation 1993;88:II-11-II-16.

254. Wood P. An appreciation of mitral stenosis: part I. BMJ 1954;1:1051-1063.

255. Rowe JC, Bland EF, Sprague HB. The course of mitral stenosis without surgery: ten and twenty year perspectives. Ann Intern Med 1960;52:741-749.

256. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962;24:349-357.

257. Roberts WC, Perloff JK. Mitral valvular disease: a clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med 1972;77:939-975.

258. Rusted IE, Scheifley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation 1956;14:398-406.

259. Braunwald E, Moscovitz HL, Amran SS, et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular and aortic pressures: particular reference to mitral stenosis. Circulation 1955;12:69-81.

260. Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am J Cardiol 1962;10:773-784.

261. Kasalicky J, Hurych J, Widimsky R, Dejdar R, Metys R, Stanek V. Left heart haemodynamics at rest and during exercise in patients with mitral stenosis. Br Heart J 1968;30:188-195.

262. Wood P. An appreciation of mitral stenosis: part II. BMJ 1954;I:1113-1124.

263. Gorlin R. The mechanism of the signs and symptoms of mitral valve disease. Br Heart J 1954;16:375-380.

264. Halperin JL, Brooks KM, Rothlauf EB, Mindich BP, Ambrose JA, Teichholz LE. Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacement. J Am Coll Cardiol 1985;5:34-39.

265. Halperin JL, Rothlauf EB, Brooks KM, Mindich BP, Ambrose JA. Effect of nitroglycerin during hemodynamic estimation of valve orifice in patients with mitral stenosis. J Am Coll Cardiol 1987;10:342-348.

266. Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation 1972;45:878-890.

267. Munoz S, Gallardo J, Diaz-Gorrin JR, Medina O. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease. Am J Cardiol 1975;35:234-242.

268. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J 1975;37:74-78.

269. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA 1993;270:1731-1736.

270. Tuzcu EM, Block PC, Griffin BP, Newell JB, Palacios IF. Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older. Circulation 1992;85:963-971.

271. Wann LS, Weyman AE, Feigenbaum H, Dillon JC, Johnston KW, Eggleton RC. Determination of mitral valve area by cross-sectional echocardiography. Ann Intern Med 1978;88:337-341.

272. Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assessment of mitral stenosis. Circulation 1977;55:120-128.

273. Henry WL, Griffith JM, Michaelis LL, McIntosh CL, Morrow AG, Epstein SE. Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation 1975;51:827-831.

274. Martin RP, Rakowski H, Kleiman JH, Beaver W, London E, Popp RL. Reliability and reproducibility of two dimensional echocardiographic measurement of the stenotic mitral valve orifice area. Am J Cardiol 1979;43:560-568.

275. Holen J, Aaslid R, Landmark K, Simonsen S. Determination of pressure gradient in mitral stenosis with a non-invasive ultrasound Doppler technique. Acta Med Scand 1976;199:455-460.

276. Hatle L, Brubakk A, Tromsdal A, Angelsen B. Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound. Br Heart J 1978;40:131-140.

277. Rediker DE, Block PC, Abascal VM, Palacios IF. Mitral balloon valvuloplasty for mitral restenosis after surgical commissurotomy. J Am Coll Cardiol 1988;11:252-256.

278. Reid CL, McKay CR, Chandraratna PA, Kawanishi DT, Rahimtoola SH. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 1987;76:628-636.

278a. Reid CL, Chandraratna AN, Kawanishi DT, Kotlewski A, Rahimtoola SH. Influence of mitral valve morphology on double-balloon catheter balloon valvuloplasty in patients with mitral stenosis: analysis of factors predicting immediate and 3-month results. Circulation 1989;80:515-524.

279. Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 1993;21:390-397.

280. Cannan CR, Nishimura RA, Reeder GS, et al. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol 1997;29:175-180.

281. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979;60:1096-1104.

282. Nakatani S, Masuyama T, Kodama K, Kitabatake A, Fujii K, Kamada T. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation 1988;77:78-85.

283. Thomas JD, Wilkins GT, Choong CY, et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy: dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 1988;78:980-993.

284. Flachskampf FA, Weyman AE, Guerrero JL, Thomas JD. Influence of orifice geometry and flow rate on effective valve area: an in vitro study. J Am Coll Cardiol 1990;15:1173-1180.

285. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 1985;6:750-756.

286. Cheriex EC, Pieters FA, Janssen JH, de Swart H, Palmans-Meulemans A. Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol 1994;45:219-226.

287. Tamai J, Nagata S, Akaike M, et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral commissurotomy: noninvasive evaluation using continuous wave Doppler technique. Circulation 1990;81:46-51.

288. Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol 1991;17:1520-1526.

289. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863-871.

290. Okay T, Deligonul U, Sancaktar O, Kozan O. Contribution of mitral valve reserve capacity to sustained symptomatic improvement after balloon valvulotomy in mitral stenosis: implications for restenosis. J Am Coll Cardiol 1993;22:1691-1696.

291. Nakhjavan FK, Katz MR, Maranhao V, Goldberg H. Analysis of influence of catecholamine and tachycardia during supine exercise in patients with mitral stenosis and sinus rhythm. Br Heart J 1969;31:753-761.

292. Bhatia ML, Shrivastava S, Roy SB. Immediate haemodynamic effects of a beta adrenergic blocking agent-propranolol-in mitral stenosis at fixed heart rates. Br Heart J 1972;34:638-644.

293. Beiser GD, Epstein SE, Stampfer M, Robinson B, Braunwald E. Studies on digitalis, XVII: effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm. N Engl J Med 1968;278:131-137.

294. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease. Br Heart J 1970;32:26-34.

295. Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin 1973;5:131-175.

296. Daley R, Mattingly TW, Holt CL, Bland EF, White PD. Systemic arterial embolism in rheumatic heart disease. Am Heart J 1951;42:566.

297. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 1992;102:426S-433S.

298. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol 1995;25:1354-1361.

299. Adams GF, Merrett JD, Hutchinson WM, Pollock AM. Cerebral embolism and mitral stenosis: survival with and without anticoagulants. J Neurol Neurosurg Psychiatry 1974;37:378-383.

300. Caplan LR, D'Cruz I, Hier DB, Reddy H, Shah S. Atrial size, atrial fibrillation, and stroke. Ann Neurol 1986;19:158-161.

301. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991;84:527-539.

302. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-1412.

303. Levine HJ, Pauker SG, Eckman MH. Antithrombotic therapy in valvular heart disease. Chest 1995;108:360S-370S.

304. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320-1330.

305. Deverall PB, Olley PM, Smith DR, Watson DA, Whitaker W. Incidence of systemic embolism before and after mitral valvotomy. Thorax 1968;23:530-536.

306. Kellogg F, Lui CK, Fishman W, Larson R. Systemic and pulmonary emboli before and after mitral commissurotomy. Circulation 1961;24:263.

307. Gorlin R, Sawyer CG, Haynes FW, Goodal WL, Dexter L. Effects of exercise on circulatory dynamics in mitral stenosis. Am Heart J 1951;41:192-203.

308. Harvey RM, Ferrer MI, Samet P, et al. Mechanical and myocardial factors in rheumatic heart disease in mitral stenosis. Circulation 1955;11:531.

309. Nishimura RA, Rihal CS, Tajik AJ, Holmes DR Jr. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol 1994;24:152-158.

310. Dahl JC, Winchell P, Borden CW. Mitral stenosis: a long term postoperative follow-up. Arch Intern Med 1967;119:92-97.

311. Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty. Circulation 1973;48:357-364.

312. John S, Bashi VV, Jairaj PS, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation 1983;68:891-896.

313. Finnegan JO, Gray DC, MacVaugh H III, Joyner CR, Johnson J. The open approach to mitral commissurotomy. J Thorac Cardiovasc Surg 1974;67:75-82.

314. Halseth WL, Elliott DP, Walker EL, Smith EA. Open mitral commissurotomy: a modern re-evaluation. J Thorac Cardiovasc Surg 1980;80:842-848.

315. Gross RI, Cunningham JN, Snively SL, et al. Long-term results of open radical mitral commissurotomy: ten year follow-up study of 202 patients. Am J Cardiol 1981;47:821-825.

316. Mullin MJ, Engelman RM, Isom OW, Boyd AD, Glassman E, Spencer FC. Experience with open mitral commissurotomy in 100 consecutive patients. Surgery 1974;76:974-982.

317. Kawanishi DT, Rahimtoola SH. Catheter balloon commissurotomy for mitral stenosis: complications and results. J Am Coll Cardiol 1992;19:192-195.

318. Multicenter experience with balloon mitral commissurotomy. NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants. Circulation 1992;85:448-461.

319. Feldman T. Hemodynamic results, clinical outcome, and complications of Inoue balloon mitral valvotomy. Cathet Cardiovasc Diagn 1994;suppl 2:2-7.

320. Cohen DJ, Kuntz RE, Gordon SP, et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992;327:1329-1335.

321. Complications, and mortality of percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. Circulation 1992;85:2014-2024.

322. Orrange SE, Kawanishi DT, Lopez BM, Curry SM, Rahimtoola SH. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation 1997;95:382-389.

323. Dean LS, Mickel M, Bonan R, et al. Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J Am Coll Cardiol 1996;28:1452-1457.

324. Palacios IF, Tuzcu ME, Weyman AE, Newell JB, Block PC. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation 1995;91:671-676.

325. Patel JJ, Shama D, Mitha AS, et al. Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study. J Am Coll Cardiol 1991;18:1318-1322.

326. Arora R, Nair M, Kalra GS, Nigam M, Khalilullah M. Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study. Am Heart J 1993;125:1091-1094.

327. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331:961-967.

328. Turi ZG, Reyes VP, Raju BS, et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis: a prospective, randomized trial. Circulation 1991;83:1179-1185.

329. Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998;97:245-250.

330. Padial LR, Freitas N, Sagie A, et al. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J Am Coll Cardiol 1996;27:1225-1231.

331. Post JR, Feldman T, Isner J, Herrmann HC. Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. J Am Coll Cardiol 1995;25:1129-1136.

332. Yasu T, Katsuki T, Ohmura N, et al. Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy. Am J Cardiol 1996;77:492-497.

333. McKay CR, Kawanishi DT, Kotlewski A, et al. Improvement in exercise capacity and exercise hemodynamics 3 months after double-balloon, catheter balloon valvuloplasty treatment of patients with symptomatic mitral stenosis. Circulation 1988;77:1013-1021.

334. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. N Engl J Med 1967;277:387-394.

335. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes DR Jr. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol 1992;20:781-786.

336. Braunwald E, Braunwald NS, Ross JJ, Morrow AG. Effects of mitral valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 1965;273:509.

337. Higgs LM, Glancy DL, O'Brien KP, Epstein SE, Morrow AG. Mitral restenosis: an uncommon cause of recurrent symptoms following mitral commissurotomy. Am J Cardiol 1970;26:34-37.

338. Abascal VM, Wilkins GT, Choong CY, et al. Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol 1988;12:606-615.

339. Jang IK, Block PC, Newell JB, Tuzcu EM, Palacios IF. Percutaneous mitral balloon valvotomy for recurrent mitral stenosis after surgical commissurotomy. Am J Cardiol 1995;75:601-605.

340. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol 1991;16:309-375.

341. Crawford MH, O'Rourke RA. Mitral valve prolapse syndrome. In: Isselbacher KJ, Adams RD, Braunwald E, eds. Harrison's Principles of Internal Medicine: Update I. New York, NY: McGraw-Hill Publishing Co; 1981:91-152.

342. Perloff JK, Roberts WC. The mitral apparatus: functional anatomy of mitral regurgitation. Circulation 1972;46:227-239.

343. O'Rourke RA. The mitral valve prolapse syndrome. In: Chizner MA, ed. Classic Teachings in Clinical Cardiology: A Tribute to W Proctor Harvey, M. D., Cedar Grove, New Jersey: Laennec Publishing Co; 1996:1049-1070.

344. Levine HJ, Isner JM, Salem DN. Primary versus secondary mitral valve prolapse: clinical features and implications. Clin Cardiol 1982;5:371-375.

345. Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr Probl Cardiol 1982;7:1-48.

346. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med 1982;97:826-832.

347. Shell WE, Walton JA, Clifford ME, Willis PW III. The familial occurrence of the syndrome of mid-late systolic click and late systolic murmur. Circulation 1969;39:327-337.

348. Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med 1980;92:171-178.

349. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med 1982;307:228-231.

350. Schwarz T, Gotsman MS. Mitral valve prolapse in osteogenesis imperfecta. Isr J Med Sci 1981;17:1087-1088.

351. Salomon J, Shah PM, Heinle RA. Thoracic skeletal abnormalities in idiopathic mitral valve prolapse. Am J Cardiol 1975;36:32-36.

352. Rosenberg CA, Derman GH, Grabb WC, Buda AJ. Hypomastia and mitral-valve prolapse: evidence of a linked embryologic and mesenchymal dysplasia. N Engl J Med 1983;309:1230-1232.

353. Tei C, Sakamaki T, Shah PM, et al. Mitral valve prolapse in short-term experimental coronary occlusion: a possible mechanism of ischemic mitral regurgitation. Circulation 1983;68:183-189.

354. Crawford MH. Mitral valve prolapse due to coronary artery disease. Am J Med 1977;62:447-451.

355. Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 1991;52:1246-1251.

356. Tomaru T, Uchida Y, Mohri N, Mori W, Furuse A, Asano K. Postinflammatory mitral and aortic valve prolapse: a clinical and pathological study. Circulation 1987;76:68-76.

357. Lembo NJ, Dell'Italia LJ, Crawford MH, Miller JF, Richards KL, O'Rourke RA. Mitral valve prolapse in patients with prior rheumatic fever. Circulation 1988;77:830-836.

358. Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989;63:577-584.

359. Crawford MH, O'Rourke RA. Mitral valve prolapse: a cardiomyopathic state? Prog Cardiovasc Dis 1984;27:133-139.

360. Lax D, Eicher M, Goldberg SJ. Mild dehydration induces echocardiographic signs of mitral valve prolapse in healthy females with prior normal cardiac findings. Am Heart J 1992;124:1533-1540.

361. Krivokapich J, Child JS, Dadourian BJ, Perloff JK. Reassessment of echocardiographic criteria for diagnosis of mitral valve prolapse. Am J Cardiol 1988;61:131-135.

362. Gaffney FA, Karlsson ES, Campbell W, et al. Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 1979;59:894-901.

363. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome: a neuroendocrine-cardiovascular process. Circulation 1980;61:1200-1205.

364. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 1983;2:638-644.

365. Gaffney FA, Bastian BC, Lane LB, et al. Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol 1983;52:316-320.

366. Allen H, Harris A, Leatham A. Significance and prognosis of an isolated late systolic murmur: a 9- to 22-year follow-up. Br Heart J 1974;36:525-532.

367. Mills P, Rose J, Hollingsworth J, Amara I, Craige E. Long-term prognosis of mitral-valve prolapse. N Engl J Med 1977;297:13-18.

368. Nishimura RA, McGoon MD, Shub C, Miller FA, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse: long- term follow-up of 237 patients. N Engl J Med 1985;313:1305-1309.

369. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse. Disproportionate occurrence in men and older patients. Am J Med 1986;81:751-758.

370. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol 1995;75:1028-1032.

371. Duren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol 1988;11:42-47.

372. Boudoulas H, Kohbash BH, Wooley CF. Mitral valve prolapse: a heterogenous disorder. Prim Cardiol 1991;17:29-43.

373. Cheitlin MD, Byrd RC. Prolapsed mitral valve: the commonest valve disease? Curr Probl Cardiol 1984;8:1-54.

374. Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation. Pacing Clin Electrophysiol 1993;16:387-393.

375. Martini B, Basso C, Thiene G. Sudden death in mitral valve prolapse with Holter monitoring-documented ventricular fibrillation: evidence of coexisting arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 1995;49:274-278.

376. Puddu PE, Pasternac A, Tubau JF, Krol R, Farley L, de Champlain J. QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J 1983;105:422-428.

377. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med 1982;307:776-781.

378. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol 1994;74:1024-1029.

379. Wilson LA, Keeling PW, Malcolm AD, Russel RW, Webb-Peploe MM. Visual complications of mitral leaflet prolapse. BMJ 1977;2:86-88.

380. Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980;302:139-144.

381. O'Rourke RA, Crawford MH. The systolic click-murmur syndrome: clinical recognition and management. Curr Probl Cardiol 1976;1:1-60.

382. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989;320:1031-1036.

383. Shah PM. Echocardiographic diagnosis of mitral valve prolapse. J Am Soc Echocardiogr 1994;7:286-293.

384. Zuppiroli A, Mori F, Favilli S, et al. Arrhythmias in mitral valve prolapse: relation to anterior mitral leaflet thickening, clinical variables, and color Doppler echocardiographic parameters. Am Heart J 1994;128:919-927.

385. Babuty D, Cosnay P, Breuillac JC, et al. Ventricular arrhythmia factors in mitral valve prolapse. Pacing Clin Electrophysiol 1994;17:1090-1099.

386. Takamoto T, Nitta M, Tsujibayashi T, Taniguchi K, Marumo F. The prevalence and clinical features of pathologically abnormal mitral valve leaflets (myxomatous mitral valve) in the mitral valve prolapse syndrome: an echocardiographic and pathological comparative study. J Cardiol Suppl 1991;25:75-86.

387. Chandraratna PA, Nimalasuriya A, Kawanishi D, Duncan P, Rosin B, Rahimtoola SH. Identification of the increased frequency of cardiovascular abnormalities associated with mitral valve prolapse by two-dimensional echocardiography. Am J Cardiol 1984;54:1283-1285.

388. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-1423.

389. Barletta GA, Gagliardi R, Benvenuti L, Fantini F. Cerebral ischemic attacks as a complication of aortic and mitral valve prolapse. Stroke 1985;16:219-223.

390. Boughner DR, Barnett HJ. The enigma of the risk of stroke in mitral valve prolapse. Stroke 1985;16:175-177.

391. Barnett HJ, Jones MW, Boughner DR, Kostuk WJ. Cerebral ischemic events associated with prolapsing mitral valve. Arch Neurol 1976;33:777-782.

392. Winkle RA, Lopes MG, Goodman DJ, Fitzgerald JW, Schroeder JS, Harrison DC. Propranolol for patients with mitral valve prolapse. Am Heart J 1977;93:422-427.

393. Schaal SF. Ventricular arrhythmias in patients with mitral valve prolapse. Cardiovasc Clin 1992;22:307-316.

394. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322:863-868.

395. Hart RG, Halperin JL. Atrial fibrillation and stroke: revisiting the dilemmas. Stroke 1994;25:1337-1341.

396. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994;74:374-380.

397. Engel PJ, Alpert BL, Hickman JR Jr. The nature and prevalence of the abnormal exercise electrocardiogram in mitral valve prolapse. Am Heart J 1979;98:716-724.

398. Butman S, Chandraratna PA, Milne N, Olson H, Lyons K, Aronow WS. Stress myocardial imaging in patients with mitral valve prolapse: evidence of a perfusion abnormality. Cathet Cardiovasc Diagn 1982;8:243-252.

399. Carabello BA. Mitral regurgitation: basic pathophysiologic principles. Part 1. Mod Concepts Cardiovasc Dis 1988;57:53-58.

400. Castello R, Fagan LJ, Lenzen P, Pearson AC, Labovitz AJ. Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 1991;68:1677-1680.

401. Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr. Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease. J Am Coll Cardiol 1990;16:1575-1578.

402. Connolly MW, Gelbfish JS, Jacobowitz IJ, et al. Surgical results for mitral regurgitation from coronary artery disease. J Thorac Cardiovasc Surg 1986;91:379-388.

403. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979;43:773-777.

404. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of the subvalvular apparatus. Circulation 1973;48:684-690.

405. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984;3:235-242.

406. Schuler G, Peterson KL, Johnson A, et al. Temporal response of left ventricular performance to mitral valve surgery. Circulation 1979;59:1218-1231.

407. Carabello BA, Nolan SP, McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981;64:1212-1217.

408. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement: Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990;81:1173-1181.

409. Simonson JS, Schiller NB. Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 1988;11:557-564.

410. Tischler MD, Battle RW, Saha M, Niggel J, LeWinter MM. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol 1995;25:128-133.

411. Phillips HR, Levine FH, Carter JE, et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 1981;48:647-654.

412. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-837.

413. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191-197.

414. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, Krayenbuehl HP. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation 1987;76:59-67.

415. Gaasch WH, Zile MR. Left ventricular function after surgical correction of chronic mitral regurgitation. Eur Heart J 1991;12(suppl B):48-51.

416. Schon HR, Schroter G, Barthel P, Schomig A. Quinapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994;3:303-312.

417. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol 1985;6:744-749.

418. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993;72:840-843.

419. Croft CH, Lipscomb K, Mathis K, et al. Limitations of qualitative angiographic grading in aortic or mitral regurgitation. Am J Cardiol 1984;53:1593-1598.

420. Fuchs RM, Heuser RR, Yin FC, Brinker JA. Limitations of pulmonary wedge V waves in diagnosing mitral regurgitation. Am J Cardiol 1982;49:849-854.

421. Duran CG, Pomar JL, Revuelta JM, et al. Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg 1980;79:326-337.

422. Yacoub M, Halim M, Radley-Smith R, McKay R, Nijveld A, Towers M. Surgical treatment of mitral regurgitation caused by floppy valves: repair versus replacement. Circulation 1981;64:II-210-II-216.

423. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983;68:II-76-II-82.

424. Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation of mitral valve repair and replacement with Starr, Bjork, and porcine valve prostheses. Circulation 1984;70:I-187-I-192.

425. Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study. J Am Coll Cardiol 1987;10:568-575.

426. Tischler MD, Cooper KA, Rowen M, LeWinter MM. Mitral valve replacement versus mitral valve repair: a Doppler and quantitative stress echocardiographic study. Circulation 1994;89:132-137.

427. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis. Circulation 1995;91:1022-1028.

428. Rushmer RF. Initial phase of ventricular systole: asynchronous contraction. Am J Physiol 1956;184:188-194.

429. David TE, Burns RJ, Bacchus CM, Druck MN. Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae. J Thorac Cardiovasc Surg 1984;88:718-725.

430. Hennein HA, Swain JA, McIntosh CL, Bonow RO, Stone CD, Clark RE. Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement. J Thorac Cardiovasc Surg 1990;99:828-836.

431. Rozich JD, Carabello BA, Usher BW, Kratz JM, Bell AE, Zile MR. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: mechanisms for differences in postoperative ejection performance. Circulation 1992;86:1718-1726.

432. Horskotte D, Schulte HD, Bircks W, Strauer BE. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. J Heart Valve Dis 1993;2:150-158.

433. Gaasch WH, John RM, Aurigemma GP. Managing asymptomatic patients with chronic mitral regurgitation. Chest 1995;108:842-847.

434. Ross J Jr. The timing of surgery for severe mitral regurgitation. N Engl J Med 1996;335:1456-1458.

435. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997;337:32-41.

436. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994;24:1536-1543.

437. Reed D, Abbott RD, Smucker ML, Kaul S. Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation: the importance of left atrial size. Circulation 1991;84:23-34.

438. Betriu A, Chaitman BR, Almazan A. Preoperative determinants of return to sinus rhythm after valve replacement. In: Cohn LH, Gallucci V, eds. Cardiac Bioprosthesis. New York, NY: Yorke Medical Books; 1982:184-191.

439. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atria fibrillation: should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994;107:408-415.

440. Craver JM, Cohen C, Weintraub WS. Case-matched comparison of mitral valve replacement and repair. Ann Thorac Surg 1990;49:964-969.

441. Wells FC. Conservation and surgical repair of the mitral valve. In: Wells FC, Shapiro LM, eds. Mitral Valve Disease. 2nd ed. Oxford, UK: Butterworth-Heinemann; 1996:114-134.

442. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg. 1994;58:668-675; discussion 675-676.

443. Edmunds LH Jr. Ischemic mitral regurgitation. In: Edmunds LHJ, ed. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill Publishing Co; 1997:657-676.

444. Cohn LH, Rizzo RJ, Adams DH, et al. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg 1995;9:568-574.

445. Burwash IG, Thomas DD, Sadahiro M, et al. Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in valvular aortic stenosis. Circulation 1994;89:827-835.

446. Lorell DH, Grossman W. Dynamic and isometric exercise during cardiac catheterization. In: Baim DS, Grossman W, eds. Cardiac Catheterization, Angiography, and Intervention. 5th ed. Baltimore, MD: Williams & Wilkins; 1996:281-296.

447. Sheehan FH, Mitten-Lewis S. Factors influencing accuracy in left ventricular volume determination. Am J Cardiol 1989;64:661-664.

448. Fawzy ME, Mimish L, Sivanandam V, et al. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis. Am Heart J 1996;131:89-93.

449. Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation. Am J Cardiol 1994;73:209-211.

450. Duran CM. Tricuspid valve surgery revisited. J Card Surg 1994;9:242-247.

451. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation: part III. Clin Cardiol 1995;18:225-230.

452. Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA, Pless JE. Etiology of pure tricuspid regurgitation based on annular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. J Am Coll Cardiol 1986;7:1063-1074.

453. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation: part I. Clin Cardiol 1995;18:97-102.

454. Wooley CF, Fontana ME, Kilman JW, Ryan JM. Tricuspid stenosis: atrial systolic murmur, tricuspid opening snap, and right atrial pressure pulse. Am J Med 1985;78:375-384.

455. Naylor CD. Systolic propulsion of the eyeballs in tricuspid regurgitation. Lancet 1995;346:1706.

456. Hollins GW, Engeset J. Pulsatile varicose veins associated with tricuspid regurgitation. Br J Surg 1989;76:207.

457. Amidi M, Irwin JM, Salerni R, et al. Venous systolic thrill and murmur in the neck: a consequence of severe tricuspid insufficiency. J Am Coll Cardiol 1986;7:942-945.

458. Rivera JM, Vandervoort PM, Vazquez de Prada JA, et al. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? Am J Cardiol 1993;72:1305-1309.

459. Yada I, Tani K, Shimono T, Shikano K, Okabe M, Kusagawa M. Preoperative evaluation and surgical treatment for tricuspid regurgitation associated with acquired valvular heart disease: the Kay-Boyd method vs the Carpentier-Edwards ring method. J Cardiovasc Surg (Torino) 1990;31:771-777.

460. Pellegrini A, Colombo T, Donatelli F, et al. Evaluation and treatment of secondary tricuspid insufficiency. Eur J Cardiothorac Surg 1992;6:288-296.

461. De Simone R, Lange R, Tanzeem A, Gams E, Hagl S. Adjustable tricuspid valve annuloplasty assisted by intraoperative transesophageal color Doppler echocardiography. Am J Cardiol 1993;71:926-931.

462. Kratz J. Evaluation and management of tricuspid valve disease. Cardiol Clin 1991;9:397-407.

463. Orbe LC, Sobrino N, Arcas R, et al. Initial outcome of percutaneous balloon valvuloplasty in rheumatic tricuspid valve stenosis. Am J Cardiol 1993;71:353-354.

464. Onate A, Alcibar J, Inguanzo R, Pena N, Gochi R. Balloon dilatation of tricuspid and pulmonary valves in carcinoid heart disease. Tex Heart Inst J 1993;20:115-119.

465. Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol 1994;24:696-702.

466. Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S. Tricuspid valve reconstruction: a treatment option in acute endocarditis. Eur J Cardiothorac Surg 1996;10:320-326.

467. Sutlic Z, Schmid C, Borst HG. Repair of flail anterior leaflets of tricuspid and mitral valves by cusp remodeling. Ann Thorac Surg 1990;50:927-930.

468. Choi JB, Kim HK, Yoon HS, Jeong JW. Partial annular plication for atrioventricular valve regurgitation. Ann Thorac Surg 1995;59:891-895.

469. Holper K, Haehnel JC, Augustin N, Sebening F. Surgery for tricuspid insufficiency: long-term follow-up after De Vega annuloplasty. Thorac Cardiovasc Surg 1993;41:1-8.

470. Peltola T, Lepojarvi M, Ikaheimo M, Karkola P. De Vega's annuloplasty for tricuspid regurgitation. Ann Chir Gynaecol 1996;85:40-43.

471. Aoyagi S, Tanaka K, Hara H, et al. Modified De Vega's annuloplasty for functional tricuspid regurgitation: early and late results. Kurume Med J 1992;39:23-32.

472. Minale C, Lambertz H, Nikol S, Gerich N, Messmer BJ. Selective annuloplasty of the tricuspid valve: two-year experience. J Thorac Cardiovasc Surg 1990;99:846-851.

473. De Paulis R, Bobbio M, Ottino G, et al. The De Vega tricuspid annuloplasty: perioperative mortality and long term follow-up. J Cardiovasc Surg (Torino) 1990;31:512-517.

474. Scully HE, Armstrong CS. Tricuspid valve replacement: fifteen years of experience with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1995;109:1035-1041.

475. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-588.

476. Thorson AH. Endocardial sclerosis and other heart lesions in the carcinoid disease. Acta Med Scand Suppl 1958;99-119.

477. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Ann Intern Med 1992;117:50-52.

478. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993;87:1188-1196.

479. Redfield MM. Ergot alkaloid heart disease. In: Hurst JW, ed. New Types of Cardiovascular Diseases: Topics in Clinical Cardiology. New York, NY: Igaku-Shoin Medical; 1994:63-76.

480. Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995;92:790-795.

481. Graham DJ, Green L. Further cases of valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:635.

482. Center for Drug Evaluation and Research. Food and Drug Administration Web site. FDA analysis of cardiac valvular dysfunction with use of appetite suppressants. Available at: http.//www.fda.gov/cder/news. Accessed October 22, 1997.

483. Langreth R, Johannes L. Diet-drug mystery grows as new research data emerge. Wall Street Journal October 31, 1997:B1.

483a. Khan MA, Herzog CA, St. Peter JV, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Eng J Med 1998;339:713-8.

483b. Jick H, Visilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Eng J Med 1998;339:719-24.

483c. Weissman NJ, Tighe JF, Gottdiener JS, Gwynne JT, for the Sustained-Release Dexfenfluramine Study Group. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained dexfenfluramine, or placebo. N Eng J Med 1998;339:725-32.

483d. Devereux RB. Appetite suppressants and valvular heart disease. N Eng J Med 1998;339:765-7.

484. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations, November 1997. MMWR Morb Mortal Wkly Rep 1997;46:1061-1066.

485. From the Centers for Disease Control and Prevention. Cardiac valvulopathy associated with exposure to fenfluramine and dexfenfluramine: US Department of Health and Human Services Interim Public Health Recommendations, November 1997. JAMA 1997;278:1729-1731.

486. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987;9:952-959.

487. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183.

488. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989;14:631-638.

489. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981;94:505-518.

490. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200-209.

491. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. JAMA 1995;274:1706-1713.

492. Nunley DL, Perlman PE. Endocarditis: changing trends in epidemiology, clinical and microbiologic spectrum. Postgrad Med 1993;93:235-238.

493. Pesanti EL, Smith IM. Infective endocarditis with negative blood cultures: an analysis of 52 cases. Am J Med 1979;66:43-50.

494. Van Scoy RE. Culture-negative endocarditis. Mayo Clin Proc 1982;57:149-154.

495. Daniel WG, Mugge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991;324:795-800.

496. Shapiro SM, Young E, De Guzman S, et al. Transesophageal echocardiography in diagnosis of infective endocarditis. Chest 1994;105:377-382.

497. Rubenson DS, Tucker CR, Stinson EB, et al. The use of echocardiography in diagnosing culture-negative endocarditis. Circulation 1981;64:641-646.

498. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994;121:873-876.

499. Kaye D. Treatment of infective endocarditis. Ann Intern Med 1996;124:606-608.

500. Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am 1993;7:97-115.

501. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation 1994;90:II-198-II-204.

502. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis: determinants of early survival and late morbidity. Circulation 1994;90:II-175-II-182.

503. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 1994;58:1073-1077.

504. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986;92:776-783.

505. Rocchiccioli C, Chastre J, Lecompte Y, Gandjbakhch I, Gibert C. Prosthetic valve endocarditis: the case for prompt surgical management. J Thorac Cardiovasc Surg 1986;92:784-789.

506. Cowgill LD, Addonizio VP, Hopeman AR, Harken AH. A practical approach to prosthetic valve endocarditis. Ann Thorac Surg 1987;43:450-457.

507. Rossiter SJ, Stinson EB, Oyer PE, et al. Prosthetic valve endocarditis: comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovasc Surg 1978;76:795-803.

508. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation 1978;58:589-597.

509. Clarkson PM, Barratt-Boyes BG. Bacterial endocarditis following homograft replacement of the aortic valve. Circulation 1970;42:987-991.

510. Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients: a comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1992;103:130-139.

511. Hendren WG, Morris AS, Rosenkranz ER, et al. Mitral valve repair for bacterial endocarditis. J Thorac Cardiovasc Surg. 1992;103:124-128; discussion 128-129.

512. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992;104:511-520.

513. Sweeney MS, Reul GJ, Cooley DA, et al. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg 1985;90:676-680.

514. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995;16(suppl B):84-89.

515. Acar J, Michel PL, Varenne O, Michaud P, Rafik T. Surgical treatment of infective endocarditis. Eur Heart J 1995;16(suppl B):94-98.

516. Cormier B, Vahanian A. Echocardiography and indications for surgery. Eur Heart J 1995;16(suppl B):68-71.

517. Lytle BW, Priest BP, Taylor PC, et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1996;111:198-207.

518. David TE. The surgical treatment of patients with prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995;7:47-53.

519. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. J Am Coll Cardiol 1991;17:1177-1182.

520. Acar C, Tolan M, Berrebi A, et al. Homograft replacement of the mitral valve: graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg. 1996;111:367-378.

521. Watanabe G, Haverich A, Speier R, Dresler C, Borst HG. Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg 1994;107:171-177.

522. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without replacement: twenty years' experience. J Thorac Cardiovasc Surg 1991;102:917-922.

523. Sett SS, Hudon MP, Jamieson WR, Chow AW. Prosthetic valve endocarditis: experience with porcine bioprostheses. J Thorac Cardiovasc Surg 1993;105:428-434.

524. David TE, Armstrong S, Sun Z, Daniel L. Late results of mitral valve repair for mitral regurgitation due to degenerative disease. Ann Thorac Surg. 1993;56:7-12; discussion 13-14.

525. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110:1745-1755.

526. Delahaye JP, Poncet P, Malquarti V, Beaune J, Gare JP, Mann JM. Cerebrovascular accidents in infective endocarditis: role of anticoagulation. Eur Heart J 1990;11:1074-1078.

527. Elkayam U. Pregnancy and cardiovascular disease. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia, Pa: WB Saunders; 1997:1843-1864.

528. de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95-100.

529. Marcus FI, Ewy GA, O'Rourke RA, Walsh B, Bleich AC. The effect of pregnancy on the murmurs of mitral and aortic regurgitation. Circulation 1970;41:795-805.

530. Campos O, Andrade JL, Bocanegra J, et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol 1993;40:265-272.

531. Iung B, Cormier B, Elias J, et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398-400.

532. Patel JJ, Mitha AS, Hassen F, et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis. Am Heart J 1993;125:1106-1109.

533. Ruzyllo W, Dabrowski M, Woroszylska M, Rydlewska-Sadowska W. Percutaneous mitral commissurotomy with the Inoue balloon for severe mitral stenosis during pregnancy. J Heart Valve Dis 1992;1:209-212.

534. Ben Farhat M, Maatouk F, Betbout F, et al. Percutaneous balloon mitral valvuloplasty in eight pregnant women with severe mitral stenosis. Eur Heart J 1992;13:1658-1664.

535. Chow WH, Chow TC, Wat MS, Cheung KL. Percutaneous balloon mitral valvotomy in pregnancy using the Inoue balloon catheter. Cardiology 1992;81:182-185.

536. Ribeiro PA, Fawzy ME, Awad M, Dunn B, Duran CG. Balloon valvotomy for pregnant patients with severe pliable mitral stenosis using the Inoue technique with total abdominal and pelvic shielding. Am Heart J 1992;124:1558-1562.

537. Kultursay H, Turkoglu C, Akin M, Payzin S, Soydas C, Akilli A. Mitral balloon valvuloplasty with transesophageal echocardiography without using fluoroscopy. Cathet Cardiovasc Diagn 1992;27:317-321.

538. Esteves CA, Ramos AI, Braga SL, Harrison JK, Sousa JE. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy. Am J Cardiol 1991;68:930-934.

539. Palacios IF, Block PC, Wilkins GT, Rediker DE, Daggett WM. Percutaneous mitral balloon valvotomy during pregnancy in a patient with severe mitral stenosis. Cathet Cardiovasc Diagn 1988;15:109-111.

540. Safian RD, Berman AD, Sachs B, et al. Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis. Cathet Cardiovasc Diagn 1988;15:103-108.

541. Pavankumar P, Venugopal P, Kaul U, et al. Closed mitral valvotomy during pregnancy: a 20-year experience. Scand J Thorac Cardiovasc Surg 1988;22:11-15.

542. Lao TT, Adelman AG, Sermer M, Colman JM. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol 1993;100:1141-1142.

543. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 1993;70:544-545.

544. Sheikh F, Rangwala S, DeSimone C, Smith HS, O'Leary AM. Management of the parturient with severe aortic incompetence. J Cardiothorac Vasc Anesth 1995;9:575-577.

545. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995;173:1599-1606.

546. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 1995;123:117-122.

547. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-1341.

548. Goldstein I, Jakobi P, Gutterman E, Milo S. Umbilical artery flow velocity during maternal cardiopulmonary bypass. Ann Thorac Surg 1995;60:1116-1118.

549. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59-75.

550. Rossouw GJ, Knott-Craig CJ, Barnard PM, Macgregor LA, Van Zyl WP. Intracardiac operation in seven pregnant women. Ann Thorac Surg 1993;55:1172-1174.

551. Jayaram A, Carp HM, Davis L, Jacobson SL. Pregnancy complicated by aortic dissection: caesarean delivery during extradural anaesthesia. Br J Anaesth 1995;75:358-360.

552. Wahlers T, Laas J, Alken A, Borst HG. Repair of acute type A aortic dissection after cesarean section in the thirty-ninth week of pregnancy. J Thorac Cardiovasc Surg 1994;107:314-315.

553. Jamieson WR, Miller DC, Akins CW, et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 1995;60:S282-S286.

554. Dore A, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 1997;18:1659-1662.

555. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-1393.

556. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201.

557. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet 1993;45:17-21.

558. Hirsh J, Fuster V. Guide to anticoagulant therapy, part 2: oral anticoagulants. American Heart Association. Circulation 1994;89:1469-1480.

559. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-1703.

560. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1995;108:305S-311S.

561. Oakley CM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1643-1644.

562. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320-1330.

563. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704-1706.

564. Turpie AG, Gent M, Laupacis A, et al. Comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement. N Engl J Med 1993;329:524-529.

565. Moller JH, Taubert KA, Allen HD, Clark EB, Lauer RM. Cardiovascular health and disease in children: current status. A special writing group from the Task Force on Children and Youth, American Heart Association. Circulation 1994;89:923-930.

566. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulations of myocardial mechanics: age-and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992;19:619-629.

567. Wagner HR, Ellison RC, Keane JF, Humphries OJ, Nadas AS. Clinical course in aortic stenosis. Circulation 1977;56:I-147-I-156.

568. Keane JF, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: results of treatment of patients with aortic valvar stenosis. Circulation 1993;87:I-16-I-27.

569. McCrindle BW. Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children: Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Am J Cardiol 1996;77:286-293.

570. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success. J Am Coll Cardiol 1996;27:1257-1263.

571. Lambert EC, Menon V, Wagner HR, Vlad P. Sudden unexpected death from cardiovascular disease in children: a cooperative international study. Am J Cardiol 1974;34:89-96.

572. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967;2:956-958.

573. Matsuki O, Okita Y, Almeida RS, et al. Two decades' experience with aortic valve replacement with pulmonary autograft. J Thorac Cardiovasc Surg 1988;95:705-711.

574. Chambers JC, Somerville J, Stone S, Ross DN. Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. Circulation 1997;96:2206-2214.

575. Elkins RC, Knott-Craig CJ, Ward KE, Lane MM. The Ross operation in children: 10-year experience. Ann Thorac Surg 1998;65:496-502.

576. Ruckman RN, Van Praagh R. Anatomic types of congenital mitral stenosis: report of 49 autopsy cases with consideration of diagnosis and surgical implications. Am J Cardiol 1978;42:592-601.

577. Moore P, Adatia I, Spevak PJ, et al. Severe congenital mitral stenosis in infants. Circulation 1994;89:2099-2106.

578. Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE. Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol 1992;19:1041-1046.

579. Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994;23:170-176.

580. Koretzky ED, Moller JH, Korns ME, Schwartz CJ, Edwards JE. Congenital pulmonary stenosis resulting from dysplasia of valve. Circulation 1969;40:43-53.

581. Nadas AS, Ellison RC, Weidman WH, eds. Report from the joint study on the Natural History of Congenital Heart Defects. Circulation 1977;56(suppl I):I-1-I-87.

582. O'Fallon WM, Weidman WH, eds. Long-term follow-up of congenital aortic stenosis, pulmonary stenosis, and ventricular septal defect: report from the Second Joint Study on the Natural History of Congenital Heart Defects (NHS-2). Circulation 1993;87(suppl I):I-1-I-126.

583. Brock RC. The surgical treatment of pulmonic stenosis. Br Heart J 1961;23:337-343.

584. Jonas RA, Castaneda AR, Norwood WI, Freed MD. Pulmonary valvotomy under normothermic caval inflow occlusion. Aust N Z J Surg 1985;55:39-44.

585. Kan JS, White RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med 1982;307:540-542.

586. Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR. Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990;65:775-783.

587. Kaul UA, Singh B, Tyagi S, Bhargava M, Arora R, Khalilullah M. Long-term results after balloon pulmonary valvuloplasty in adults. Am Heart J 1993;126:1152-1155.

588. Chen CR, Cheng TO, Huang T, et al. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults. N Engl J Med 1996;335:21-25.

589. McCrindle BW. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Circulation 1994;89:1751-1759.

590. Driscoll DJ, Allen HD, Atkins DL, et al. Guidelines for evaluation and management of common congenital cardiac problems in infants, children and adolescents: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;90:2180-2188.

591. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993;329:593-599.

592. Harken D, Soroff HS, Taylor WJ. Partial and complete prosthesis in aortic insufficiency. J Thorac Cardiovasc Surg 1960;40:744.

593. Starr A, Edwards M. Mitral replacement: clinical experience with a ball valve prosthesis. Ann Surg 1961;154:726-740.

594. Bjork VO. A new tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg 1969;3:1-10.

595. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487.

596. Barratt-Boyes B. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964;19:131-135.

597. Carpentier A, Dubost C. From xenograft to bioprosthesis. In: Ionescu MI, Ross DN, Wooler GH, eds. Biological Tissue in Heart Valve Replacement. London, UK: Butterworth-Heinemann; 1971:515-541.

598. Duvoisin GE, Brandenburg RO, McGoon DC. Factors affecting thromboembolism associated with prosthetic heart valves. Circulation 1967;35:I70-I76.

599. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn 1958;53:457-481.

600. Stinson EB, Griepp RB, Oyer PE, Shumway NE. Long-term experience with porcine aortic valve xenografts. J Thorac Cardiovasc Surg 1977;73:54-63.

601. Grunkemeier GL, Thomas DR, Starr A. Statistical considerations in the analysis and reporting of time-related events. Application to analysis of prosthetic valve-related thromboembolism and pacemaker failure. Am J Cardiol 1977;39:257-258.

602. Grunkemeier GL, Macmanus Q, Thomas DR, Starr A. Regression analysis of late survival following mitral valve replacement. J Thorac Cardiovasc Surg 1978;75:131-137.

603. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of time-varying hazard into separate phases, each incorporating a separate stream of concomitant information. J Am Stat Assn 1986;81:615-624.

604. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-259.

605. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: the American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-935.

606. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the American Association for Thoracic Surgery and the Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711.

607. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation 1978;58:20-24.

608. Grunkemeier GL, Starr A, Rahimtoola SH. Prosthetic heart valve performance: long-term follow-up. Curr Probl Cardiol 1992;17:329-406.

609. Rahimtoola SH. Lessons learned about the determinants of the results of valve surgery. Circulation 1988;78:1503-1507.

610. Grunkemeier GL, Starr A, Rahimtoola SH. Clinical performance of prosthetic heart valves. In: Schlant RA, Alexander RW, eds. Hurst's The Heart. 9th ed. New York, NY: McGraw-Hill Publishing Co; 1998:1851-1866.

611. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.

612. Rahimtoola SH. Some unexpected lessons from large multicenter randomized clinical trials. Circulation 1985;72:449-455.

613. Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis 1992;1:142-151.

614. Hammermeister KE, Sethi GK, Henderson WG, Rahimtoola SH. Comparison of outcomes 16 years after randomization to valve replacement with a bioprosthetic or mechanical prosthetic valve. Circulation 1996;94:I-650. Abstract.

615. Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different 'models' of homograft valves. J Heart Valve Dis 1994;3:556-560.

616. Grunkemeier G, Starr A, Rahimtoola SH. Replacement of heart valves. In: O'Rourke RA, ed. The Heart: Update I. New York, NY: McGraw-Hill Publishing Co; 1996:98-123.

617. McAnulty JH, Rahimtoola SH. Antithrombotic therapy in valvular heart disease. In: Schlant R, Alexander RW, eds. Hurst's The Heart, Arteries, and Veins. 9th ed. New York, NY: McGraw-Hill Publishing Co; 1998:1867-1874.

618. Cobanoglu A, Fessler CL, Guvendik L, Grunkemeier G, Starr A. Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up. Ann Thorac Surg 1988;45:248-252.

619. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641.

620. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-1119.

621. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.

622. Jegaden O, Eker A, Delahaye F, et al. Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve. Ann Thorac Surg. 1994;58:1721-1728; discussion 1727-1728.

623. Saour JN, Sieck JO, Mamo LA, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-432.

624. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors: recommendations for the Medtronic Hall valve. Circulation 1991;84:III-61-III-69.

625. Acar J, Iung B, Boissel JP, et al. AREVA. multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-2112.

626. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: experience with 1,004 Medtronic Hall valves. Circulation 1988;78:I-66-I-77.

627. Vogt S, Hoffmann A, Roth J, et al. Heart valve replacement with the Bjork-Shiley and St Jude Medical prostheses: a randomized comparison in 178 patients. Eur Heart J 1990;11:583-591.

628. Horstkotte D, Schulte H, Bircks W, Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude medical prostheses. J Heart Valve Dis 1993;2:291-301.

629. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude medical prosthesis. J Thorac Cardiovasc Surg. 1994;107:1136-1145.

630. Stein PD, Alpert JS, Dalen JE, Horstkotte D, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest In press.

631. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;31:749-753.

632. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.

633. Hayashi J, Nakazawa S, Oguma F, Miyamura H, Eguchi S. Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease. J Am Coll Cardiol 1994;23:672-677.

634. Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991;101:427-431.

635. Albertal J, Sutton M, Pereyra D, et al. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study. J Heart Valve Dis 1993;2:302-307.

636. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis. Am Heart J 1995;130:547-552.

637. Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113:910-916.

638. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk: the Medical Research Council's General Practice Research Framework. Lancet 1998;351:233-241.

639. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G. Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects. Chest 1995;108:247S-257S.

640. Turpie AG. Antithrombotic therapy after heart valve replacement. In: Yusuf S, Cairns J, Camm J, Fallen E, Gersh B, eds. Evidence Based Cardiology. London, UK: BMJ Publishing Groups; 1998:905-911.

641. Altman R, Boullon F, Rouvier J, Raca R, de la Fuente L, Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg 1976;72:127-129.

642. Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves. Am Heart J 1977;94:101-111.

643. Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983;51:1537-1541.

644. Turpie AG, Gunstensen J, Hirsh J, Nelson H, Gent M. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988;1:1242-1245.

645. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 1997;126:959-962.

646. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996;92:479-485.

647. Eckman MH, Beshansky JR, Durand-Zaleski I, Levine HJ, Pauker SG. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves: does low risk mean high cost? JAMA 1990;263:1513-1521.

648. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-1511.

649. Bryan AJ, Butchart EG. Prosthetic heart valves and anticoagulant management during non-cardiac surgery. Br J Surg 1995;82:577-578.

650. Busuttil WJ, Fabri BM. The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations. Postgrad Med J 1995;71:390-392.

651. Tinker JH, Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: observations in 180 operations. JAMA 1978;239:738-739.

652. Moreno-Cabral RJ, McNamara JJ, Mamiya RT, Brainard SC, Chung GK. Acute thrombotic obstruction with Bjork-Shiley valves: diagnostic and surgical considerations. J Thorac Cardiovasc Surg 1978;75:321-330.

653. Copans H, Lakier JB, Kinsley RH, Colsen PR, Fritz VU, Barlow JB. Thrombosed Bjork-Shiley mitral prostheses. Circulation 1980;61:169-174.

654. Kontos GJ Jr, Schaff HV. Thrombotic occlusion of a prosthetic heart valve: diagnosis and management. Mayo Clin Proc 1985;60:118-122.

655. Morton MJ, McAnulty JH, Rahimtoola SH, Ahuja N. Risks and benefits of postoperative cardiac catheterization in patients with ball valve prostheses. Am J Cardiol 1977;40:870-875.

656. Lengyel M, Fuster V, Keltai M, et al. Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy: Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol 1997;30:1521-1526.

657. Hurrell DG, Schaff HV, Tajik AJ. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin Proc 1996;71:605-613.

658. Horstkotte D, Burckhardt D. Prosthetic valve thrombosis. J Heart Valve Dis 1995;4:141-153.

659. Birdi I, Angelini GD, Bryan AJ. Thrombolytic therapy for left-sided prosthetic heart valve thrombosis. J Heart Valve Dis 1995;4:154-159.

660. Rahimtoola SH. Valve prosthesis-patient mismatch: an update. J Heart Valve Dis 1998;7:207-210.

661. Rahimtoola SH. Early valve replacement for preservation of ventricular function? Am J Cardiol 1977;40:472-475.

662. Borkon AM, Soule LM, Baughman KL, et al. Aortic valve selection in the elderly patient. Ann Thorac Surg 1988;46:270-277.

663. Jamieson WR, Rosado LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 1988;46:155-162.

664. Cohn LH, Collins JJ Jr, DiSesa VJ, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg. 1989;210:435-442; discussion 442-443.

665. Jones EL, Weintraub WS, Craver JM, et al. Ten-year experience with the porcine bioprosthetic valve: interrelationship of valve survival and patient survival in 1,050 valve replacements. Ann Thorac Surg. 1990;49:370-383; discussion 383-384.

666. Pansini S, Ottino G, Caimmi F, Del Ponte S, Morea M. Risk factors of primary tissue failure within the 11th postoperative year in 217 patients with porcine bioprostheses. J Card Surg 1991;6:644-648.

667. Jamieson WR, Tyers GF, Janusz MT, et al. Age as a determinant for selection of porcine bioprostheses for cardiac valve replacement: experience with Carpentier-Edwards standard bioprosthesis. Can J Cardiol 1991;7:181-188.

668. Burr LH, Jamieson WR, Munro AI, et al. Structural valve deterioration in elderly patient populations with the Carpentier-Edwards standard and supra-annular porcine bioprostheses: a comparative study. J Heart Valve Dis 1992;1:87-91.

669. Pelletier LC, Carrier M, Leclerc Y, Dyrda I, Gosselin G. Influence of age on late results of valve replacement with porcine bioprostheses. J Cardiovasc Surg (Torino) 1992;33:526-533.

670. Burdon TA, Miller DC, Oyer PE, et al. Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg. 1992;103:238-251; discussion 251-252.

671. Jamieson WR, Burr LH, Tyers GF, Munro AI. Carpentier-Edwards standard and supra-annular porcine bioprostheses: 10 year comparison of structural valve deterioration. J Heart Valve Dis 1994;3:59-65.

672. Cosgrove DM, Lytle BW, Taylor PC, et al. The Carpentier-Edwards pericardial aortic valve: ten-year results. J Thorac Cardiovasc Surg 1995;110:651-662.

673. Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg 1996;61:615-620.

674. Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74:107-111.

675. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.

676. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-1358.

677. Ramsdale DR, Bennett DH, Bray CL, Ward C, Beton DC, Faragher EB. Angina, coronary risk factors and coronary artery disease in patients with valvular disease: a prospective study. Eur Heart J 1984;5:716-726.

678. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events: September 14-15, 1995. J Am Coll Cardiol 1996;27:957-1047.

679. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FP, Delforge MR, Carre AG. Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease: mechanism of angina pectoris in presence of normal coronary arteries. Am J Cardiol 1981;47:199-205.

680. Ross RS. Right ventricular hypertension as a cause of precordial pain. Am Heart J 1961;61:134-135.

681. Exadactylos N, Sugrue DD, Oakley CM. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br Heart J 1984;51:121-124.

682. Chobadi R, Wurzel M, Teplitsky I, Menkes H, Tamari I. Coronary artery disease in patients 35 years of age or older with valvular aortic stenosis. Am J Cardiol 1989;64:811-812.

683. Green SJ, Pizzarello RA, Padmanabhan VT, Ong LY, Hall MH, Tortolani AJ. Relation of angina pectoris to coronary artery disease in aortic valve stenosis. Am J Cardiol 1985;55:1063-1065.

684. Crochet D, Petitier H, de Laguerenne J, et al. Aortic stenosis in adults: contribution of catheterization to the study of associated lesions: apropos of 137 cases. Arch Mal Coeur Vaiss 1983;76:1057-1064.

685. Harris CN, Kaplan MA, Parker DP, Dunne EF, Cowell HS, Ellestad MH. Aortic stenosis, angina, and coronary artery disease: interrelations. Br Heart J 1975;37:656-661.

686. Morrison GW, Thomas RD, Grimmer SF, Silverton PN, Smith DR. Incidence of coronary artery disease in patients with valvular heart disease. Br Heart J 1980;44:630-637.

687. Graboys TB, Cohn PF. The prevalence of angina pectoris and abnormal coronary arteriograms in severe aortic valvular disease. Am Heart J 1977;93:683-686.

688. Hancock EW. Aortic stenosis, angina pectoris, and coronary artery disease. Am Heart J 1977;93:382-393.

689. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients. Ann Intern Med 1987;106:292-298.

690. Saltups A. Coronary arteriography in isolated aortic and mitral valve disease. Aust N Z J Med 1982;12:494-497.

691. Alexopoulos D, Kolovou G, Kyriakidis M, et al. Angina and coronary artery disease in patients with aortic valve disease. Angiology 1993;44:707-711.

692. Marchant E, Pichard A, Casanegra P. Association of coronary artery disease and valvular heart disease in Chile. Clin Cardiol 1983;6:352-356.

693. Hakki AH, Kimbiris D, Iskandrian AS, Segal BL, Mintz GS, Bemis CE. Angina pectoris and coronary artery disease in patients with severe aortic valvular disease. Am Heart J 1980;100:441-449.

694. Basta LL, Raines D, Najjar S, Kioschos JM. Clinical, haemodynamic, and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease. Br Heart J 1975;37:150-157.

695. Timmermans P, Willems JL, Piessens J, De Geest H. Angina pectoris and coronary artery disease in severe aortic regurgitation. Am J Cardiol 1988;61:826-829.

696. Pathak R, Padmanabhan VT, Tortolani AJ, Ong LY, Hall MH, Pizzarello RA. Angina pectoris and coronary artery disease in isolated, severe aortic regurgitation. Am J Cardiol 1986;57:649-651.

697. Lacy J, Goodin R, McMartin D, Masden R, Flowers N. Coronary atherosclerosis in valvular heart disease. Ann Thorac Surg 1977;23:429-435.

698. Mattina CJ, Green SJ, Tortolani AJ, et al. Frequency of angiographically significant coronary arterial narrowing in mitral stenosis. Am J Cardiol 1986;57:802-805.

699. Chun PK, Gertz E, Davia JE, Cheitlin MD. Coronary atherosclerosis in mitral stenosis. Chest 1982;81:36-41.

700. Gahl K, Sutton R, Pearson M, Caspari P, Lairet A, McDonald L. Mitral regurgitation in coronary heart disease. Br Heart J 1977;39:13-18.

701. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ, Holmes DR Jr. Secular trends in coronary atherosclerosis: analysis in patients with valvular regurgitation. N Engl J Med 1996;335:316-322.

702. Breisblatt WM, Cerqueira M, Francis CK, Plankey M, Zaret BL, Berger HJ. Left ventricular function in ischemic mitral regurgitation: a precatheterization assessment. Am Heart J 1988;115:77-82.

703. Zeldis SM, Hamby RI, Aintablian A. The clinical and hemodynamic significance of mitral regurgitation in coronary artery disease. Cathet Cardiovasc Diagn 1980;6:225-232.

704. Osbakken MD, Bove AA, Spann JF. Left ventricular regional wall motion and velocity of shortening in chronic mitral and aortic regurgitation. Am J Cardiol 1981;47:1005-1009.

705. Hecht HS, Hopkins JM. Exercise-induced regional wall motion abnormalities on radionuclide angiography: lack of reliability for detection of coronary artery disease in the presence of valvular heart disease. Am J Cardiol 1981;47:861-865.

706. Baroni M, Maffei S, Terrazzi M, Palmieri C, Paoli F, Biagini A. Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries. Heart 1996;75:492-497.

707. Kupari M, Virtanen KS, Turto H, et al. Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 1992;70:635-640.

708. Huikuri HV, Korhonen UR, Ikaheimo MJ, Heikkila J, Takkunen JT. Detection of coronary artery disease by thallium imaging using a combined intravenous dipyridamole and isometric handgrip test in patients with aortic valve stenosis. Am J Cardiol 1987;59:336-340.

709. Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects. J Am Coll Cardiol 1995;25:99-106.

710. Bailey IK, Come PC, Kelly DT, et al. Thallium-201 myocardial perfusion imaging in aortic valve stenosis. Am J Cardiol 1977;40:889-899.

711. Rask LP, Karp KH, Eriksson NP, Mooe T. Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences. Eur J Nucl Med 1995;22:1155-1162.

712. Mattila S, Harjula A, Jarvinen A, Kyllonen KE, Tala P. Combined valve replacement and myocardial revascularization: factors influencing early and late results. Scand J Thorac Cardiovasc Surg 1984;18:49-52.

713. Stahle E, Bergstrom R, Nystrom SO, Hansson HE. Early results of aortic valve replacement with or without concomitant coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 1991;25:29-35.

714. Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement in the elderly: effect of gender and coronary artery disease on operative mortality. Circulation 1993;88:II-17-II-23.

715. Donzeau-Gouge P, Blondeau P, Enriquez O, et al. Calcified aortic stenosis and coronary disease: apropos of 115 surgically-treated cases. Arch Mal Coeur Vaiss 1984;77:856-864.

716. Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher CR Jr. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation 1988;78:I-85-I-90.

717. Loop FD, Phillips DF, Roy M, Taylor PC, Groves LK, Effler DB. Aortic valve replacement combined with myocardial revascularization: late clinical results and survival of surgically-treated aortic valve patients with and without coronary artery disease. Circulation 1977;55:169-173.

718. Macmanus Q, Grunkemeier G, Lambert L, Dietl C, Starr A. Aortic valve replacement and aorta-coronary bypass surgery: results with perfusion of proximal and distal coronary arteries. J Thorac Cardiovasc Surg 1978;75:865-869.

719. Nunley DL, Grunkemeier GL, Starr A. Aortic valve replacement with coronary bypass grafting: significant determinants of ten-year survival. J Thorac Cardiovasc Surg 1983;85:705-711.

720. Bessone LN, Pupello DF, Hiro SP, Lopez-Cuenca E, Glatterer MS, Ebra G. Surgical management of aortic valve disease in the elderly: a longitudinal analysis. Ann Thorac Surg 1988;46:264-269.

721. Kay PH, Nunley D, Grunkemeier GL, Garcia C, McKinley CL, Starr A. Ten-year survival following aortic valve replacement: a multivariate analysis of coronary bypass as a risk factor. J Cardiovasc Surg (Torino) 1986;27:494-499.

722. Lytle BW, Cosgrove DM, Goormastic M, Loop FD. Aortic valve replacement and coronary bypass grafting for patients with aortic stenosis and coronary artery disease: early and late results. Eur Heart J 1988;9(suppl E):143-147.

723. Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol 1987;10:66-72.

724. Czar LSC, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg 1988;95:390-401.

725. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 1990;100:327-337.

726. Iung B, Drissi MF, Michel PL, et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. J Heart Valve Dis 1993;2:430-439.

727. Lytle BW, Cosgrove DM, Loop FD, et al. Replacement of aortic valve combined with myocardial revascularization: determinants of early and late risk for 500 patients, 1967-1981. Circulation 1983;68:1149-1162.

728. Magovern JA, Pennock JL, Campbell DB, et al. Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: predicting high risk groups. J Am Coll Cardiol 1987;9:38-43.

729. Schaff HV, Bixler TJ, Flaherty JT, et al. Identification of persistent myocardial ischemia in patients developing left ventricular dysfunction following aortic valve replacement. Surgery 1979;86:70-77.

730. Hwang MH, Hammermeister KE, Oprian C, et al. Preoperative identification of patients likely to have left ventricular dysfunction after aortic valve replacement: participants in the Veterans Administration Cooperative Study on Valvular Heart Disease. Circulation 1989;80:I-65-I-76.

731. Roberts DL, DeWeese JA, Mahoney EB, Yu PN. Long-term survival following aortic valve replacement. Am Heart J 1976;91:311-317.

732. Galvin I, Mosieri J, Paneth M, Gibson D. An analysis of isolated aortic valve surgery and combined procedures in patients over 70 years of age. J Cardiovasc Surg (Torino) 1988;29:577-581.

733. Leprince P, Tsezana R, Dorent R, et al. Reoperation for aortic valve replacement after myocardial revascularization. Arch Mal Coeur Vaiss 1996;89:335-339.

734. Fiore AC, Swartz MT, Naunheim KS, et al. Management of asymptomatic mild aortic stenosis during coronary artery operations. Ann Thorac Surg. 1996;61:1693-1697; discussion 1697-1698.

735. Hoff SJ, Merrill WH, Stewart JR, Bender HW Jr. Safety of remote aortic valve replacement after prior coronary artery bypass grafting. Ann Thorac Surg 1996;61:1689-1691.

736. Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ. Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg 1996;62:1424-1430.

737. Collins JJ, Aranki SF. Management of mild aortic stenosis during coronary artery bypass graft surgery. J Card Surg 1994;9:145-147.

© 1998 American College of Cardiology and American Heart Association, Inc.
Published by Elsevier Science Inc.